The global neobanking market size was valued at USD 34.77 billion in 2020.
Neobanks offer a complete range of banking solutions without any physical branches or offices.
The increasing demand for customer convenience in the banking sector is expected to drive the growth of the market.
Numerous neobanks operate under a freemium model, under which they offer their services for free, thus attracting a wide user base.
Additionally, neobanks can monitor the banking network and easily detect cyberattacks.
Key Player Mentioned:Atom Bank PLCFidor Bank AgMonzo Bank LimitedMovencorp Inc.MyBankN26Revolut Ltd.Simple Finance Technology CorporationApplication Segment Analysis: EnterprisesPersonalOthersProduct Segment Analysis: Business AccountSavings AccountSegmentation by Region : North AmericaEuropeAsia PacificCentral & South AmericaMiddle East & AfricaAccess Press Release @ https://www.grandviewresearch.com/press-release/global-neobanking-marketCOVID-19 Impact:The outbreak of the COVID-19 pandemic has significantly increased the demand for antiviral medicines globally.
The global neobanking market size was valued at USD 34.77 billion in 2020.
Neobanks offer a complete range of banking solutions without any physical branches or offices.
The increasing demand for customer convenience in the banking sector is expected to drive the growth of the market.
Numerous neobanks operate under a freemium model, under which they offer their services for free, thus attracting a wide user base.
Additionally, neobanks can monitor the banking network and easily detect cyberattacks.
Key Player Mentioned:Atom Bank PLCFidor Bank AgMonzo Bank LimitedMovencorp Inc.MyBankN26Revolut Ltd.Simple Finance Technology CorporationApplication Segment Analysis: EnterprisesPersonalOthersProduct Segment Analysis: Business AccountSavings AccountSegmentation by Region : North AmericaEuropeAsia PacificCentral & South AmericaMiddle East & AfricaAccess Press Release @ https://www.grandviewresearch.com/press-release/global-neobanking-marketCOVID-19 Impact:The outbreak of the COVID-19 pandemic has significantly increased the demand for antiviral medicines globally.